1. Ge, Zhen-Wei, Wang, Bao-Cai, Hu, Jun-Long, Liu, Lin, Cheng, Zhao-Yun. 2018. IRAK3 gene silencing prevents cardiac rupture and ventricular remodeling through negative regulation of the NF-κB signaling pathway in a mouse model of acute myocardial infarction. In Journal of cellular physiology, 234, 11722-11733. doi:10.1002/jcp.27827. https://pubmed.ncbi.nlm.nih.gov/30536946/
2. Gomes da Silva, Isaura Isabelle Fonseca, Barbosa, Alexandre Domingues, Souto, Fabricio Oliveira, Souza, Paulo Roberto Eleuterio de, Sandrin-Garcia, Paula. 2021. MYD88, IRAK3 and Rheumatoid Arthritis pathogenesis: Analysis of differential gene expression in CD14 + monocytes and the inflammatory cytokine levels. In Immunobiology, 226, 152152. doi:10.1016/j.imbio.2021.152152. https://pubmed.ncbi.nlm.nih.gov/34735922/
3. . 2022. Retraction. In Journal of cellular physiology, 237, 2297. doi:10.1002/jcp.30671. https://pubmed.ncbi.nlm.nih.gov/35262927/
4. Zhou, Yang, Rao, Wei, Li, Zhao, Gao, Shugeng, He, Jie. 2024. IL-1 receptor-associated kinase 3 (IRAK3) in lung adenocarcinoma predicts prognosis and immunotherapy resistance: involvement of multiple inflammation-related pathways. In Translational lung cancer research, 13, 2139-2161. doi:10.21037/tlcr-24-391. https://pubmed.ncbi.nlm.nih.gov/39430338/
5. Kuo, Chih-Chi, Shih, Yu-Lueng, Su, Her-Young, Yu, Mu-Hsien, Lin, Ya-Wen. . Methylation of IRAK3 is a novel prognostic marker in hepatocellular carcinoma. In World journal of gastroenterology, 21, 3960-9. doi:10.3748/wjg.v21.i13.3960. https://pubmed.ncbi.nlm.nih.gov/25852282/